Critics Question FDA's Approval Of Zohydro
by: Laura Sullivan, NPR, February 26, 2014 6:02:00 am
Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Prominent universities and drug addiction organizations are asking the FDA to reconsider its approval of a controversial painkiller called Zohydro. It's 10 times more powerful than OxyContin.